27660194|t|Physical Exercise for Late-Life Depression: Effects on Heart Rate Variability
27660194|a|Late-life major depression is associated with increased cardiovascular risk and impaired autonomic control of the heart, as evident from reduced heart rate variability (HRV). Moreover, antidepressant drug therapy also might be associated with further reductions of HRV. In the SEEDS study, we investigated whether sertraline associated with physical exercise protocols led to improvements of HRV, compared with antidepressant drug therapy alone. Single-blind randomized controlled trial. Psychiatric consultation -liaison program for primary care. Patients aged 65-85 years with major depression, recruited from primary care. Sertraline plus structured, tailored group physical exercise (S + EX) versus sertraline alone (S) for 24 weeks. HRV indices (RR, percentage of NN intervals greater than 50 msec [pNN50], square root of the mean squared differences of successive NN intervals [RMSSD], standard deviation of heart rate [SDHR], standard deviation of the NN interval [SDNN], high-frequency band [HF], low-frequency band [LF], and their ratio [LF/HF]) were measured at baseline, week 12, and week 24. Psychiatric and medical assessments. Participants displayed significant improvements of most HRV indices over time, irrespective of the group assignment (pNN50, RMSSD, SDHR, SDNN, HF, LF, and LF/HF). Moreover, patients in the S + EX group displayed greater increases of different HRV indices (RR, pNN50, RMSSD, SDHR, SDNN, HF, and LF) compared with those in the S group. The combination of structured physical exercise and sertraline might exert positive effects on the autonomic control of the heart among older patients with major depression.
27660194	0	17	Physical Exercise	T056	C0015259
27660194	22	31	Late-Life	T079	C2362314
27660194	32	42	Depression	T048	C0011581
27660194	44	51	Effects	T080	C1280500
27660194	55	65	Heart Rate	T201	C0018810
27660194	66	77	Variability	T077	C2827666
27660194	78	87	Late-life	T079	C2362314
27660194	88	104	major depression	T048	C1269683
27660194	108	123	associated with	T080	C0332281
27660194	124	133	increased	T081	C0205217
27660194	134	153	cardiovascular risk	T033	C1113685
27660194	158	197	impaired autonomic control of the heart	T047	C0018799
27660194	215	222	reduced	T080	C0392756
27660194	223	233	heart rate	T201	C0018810
27660194	234	245	variability	T077	C2827666
27660194	247	250	HRV	T077	C2827666
27660194	263	282	antidepressant drug	T121	C0003289
27660194	283	290	therapy	T061	C0087111
27660194	305	320	associated with	T080	C0332281
27660194	329	339	reductions	T080	C0392756
27660194	343	346	HRV	T077	C2827666
27660194	355	366	SEEDS study	T062	C2603343
27660194	392	402	sertraline	T109,T121	C0074393
27660194	403	418	associated with	T080	C0332281
27660194	419	436	physical exercise	T056	C0015259
27660194	454	466	improvements	T077	C2986411
27660194	470	473	HRV	T077	C2827666
27660194	489	508	antidepressant drug	T121	C0003289
27660194	509	516	therapy	T061	C0087111
27660194	524	536	Single-blind	T062	C0037181
27660194	537	564	randomized controlled trial	T062	C0206035
27660194	566	590	Psychiatric consultation	T073,T170	C1548378
27660194	612	624	primary care	T058	C0033137
27660194	626	634	Patients	T101	C0030705
27660194	657	673	major depression	T048	C1269683
27660194	690	702	primary care	T058	C0033137
27660194	704	714	Sertraline	T109,T121	C0074393
27660194	732	746	tailored group	UnknownType	C0681860
27660194	747	764	physical exercise	T056	C0015259
27660194	766	772	S + EX	UnknownType	C0681860
27660194	781	791	sertraline	T109,T121	C0074393
27660194	809	814	weeks	T079	C0439230
27660194	816	819	HRV	T077	C2827666
27660194	820	827	indices	T170	C0918012
27660194	833	880	percentage of NN intervals greater than 50 msec	T081	C0392762
27660194	882	887	pNN50	T081	C0392762
27660194	890	960	square root of the mean squared differences of successive NN intervals	T081	C0392762
27660194	962	967	RMSSD	T081	C0392762
27660194	970	988	standard deviation	T081	C0871420
27660194	992	1002	heart rate	T201	C0018810
27660194	1004	1008	SDHR	T081	C0871420
27660194	1011	1048	standard deviation of the NN interval	T081	C0871420
27660194	1050	1054	SDNN	T081	C0871420
27660194	1057	1076	high-frequency band	T081	C0392762
27660194	1078	1080	HF	T081	C0392762
27660194	1083	1101	low-frequency band	T081	C0392762
27660194	1103	1105	LF	T081	C0392762
27660194	1118	1123	ratio	T081	C0456603
27660194	1125	1130	LF/HF	T081	C0456603
27660194	1138	1146	measured	T080	C0444706
27660194	1150	1158	baseline	T081	C1442488
27660194	1160	1164	week	T079	C0439230
27660194	1173	1177	week	T079	C0439230
27660194	1182	1193	Psychiatric	T060	C0846574
27660194	1198	1217	medical assessments	T058	C0582103
27660194	1219	1231	Participants	T098	C0679646
27660194	1254	1266	improvements	T077	C2986411
27660194	1275	1278	HRV	T077	C2827666
27660194	1279	1286	indices	T170	C0918012
27660194	1336	1341	pNN50	T081	C0392762
27660194	1343	1348	RMSSD	T081	C0392762
27660194	1350	1354	SDHR	T081	C0871420
27660194	1356	1360	SDNN	T081	C0871420
27660194	1362	1364	HF	T081	C0392762
27660194	1366	1368	LF	T081	C0392762
27660194	1374	1379	LF/HF	T081	C0456603
27660194	1392	1400	patients	T101	C0030705
27660194	1408	1420	S + EX group	UnknownType	C0681860
27660194	1439	1448	increases	T169	C0442805
27660194	1462	1465	HRV	T077	C2827666
27660194	1466	1473	indices	T170	C0918012
27660194	1475	1477	RR	T081	C0392762
27660194	1479	1484	pNN50	T081	C0392762
27660194	1486	1491	RMSSD	T081	C0392762
27660194	1493	1497	SDHR	T081	C0871420
27660194	1499	1503	SDNN	T081	C0871420
27660194	1505	1507	HF	T081	C0392762
27660194	1513	1515	LF	T081	C0392762
27660194	1544	1551	S group	UnknownType	C0681860
27660194	1557	1568	combination	T080	C0205195
27660194	1583	1600	physical exercise	T056	C0015259
27660194	1605	1615	sertraline	T109,T121	C0074393
27660194	1628	1636	positive	T033	C1446409
27660194	1637	1644	effects	T080	C1280500
27660194	1652	1682	autonomic control of the heart	T042	C0232164
27660194	1695	1703	patients	T101	C0030705
27660194	1709	1725	major depression	T048	C1269683